The present results suggested that thiacremonone exerted its anti-inflammatory and anti-arthritic properties through the inhibition of NF-kappaB activation via interaction with the sulfhydryl group of NF-kappaB molecules, and thus could be a useful agent for the treatment of inflammatory and arthritic diseases.
No takes yet. Share an insight, caveat, or question.
Ban et al. (2009) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: